Invesco Ltd. Seagen Inc. Transaction History

Invesco Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $17.1 Million - $19.3 Million	89,440 Added 23.2%	474,948 $101 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $133 Million - $146 Million	-708,610 Reduced 64.77%	385,508 $74.2 Million
Q1 2023 May 12, 2023	SELL	$127.59 - $203.08 $17.1 Million - $27.2 Million	-134,023 Reduced 10.91%	1,094,118 $222 Million
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $15.4 Million - $18.3 Million	-131,201 Reduced 9.65%	1,228,141 $158 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $2.98 Million - $3.97 Million	22,034 Added 1.65%	1,359,342 $186 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $36.8 Million - $60.7 Million	-338,410 Reduced 20.19%	1,337,308 $237 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $1.71 Million - $2.26 Million	14,316 Added 0.86%	1,675,718 $241 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $10.7 Million - $14.3 Million	75,163 Added 4.74%	1,661,402 $257 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $87.7 Million - $105 Million	615,925 Added 63.48%	1,586,239 $269 Million
Q2 2021 Aug 17, 2021	SELL	$135.08 - $161.1 $6.25 Million - $7.46 Million	-46,289 Reduced 4.55%	970,314 $153 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $4.71 Million - $6.53 Million	-34,244 Reduced 3.26%	1,016,603 $141 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $173 Million - $223 Million	1,050,847 New	1,050,847 $184 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.